December 9, 2021
Highlights include clinical, real-world and health economic findings from studies of blood cancer treatments and hematological side effects in the community oncology setting THE WOODLANDS, Texas, Dec. 9, 2021 — Investigators from US Oncology Research, The US Oncology Network (The Network), and OntadaTM will share results from more than 30 studies exploring areas such as […]
Read MoreNovember 16, 2021
Practices using Oncology Care Model improved patient care while saving Medicare $197 million THE WOODLANDS, TEXAS, Nov. 16, 2021 — The Centers for Medicare & Medicaid Innovation (CMMI) recently released results for the 8th Performance Period (PP8) of the Oncology Care Model (OCM), and practices in The US Oncology Network (The Network) participating in the program […]
Read MoreSeptember 20, 2021
Successor will continue The Network’s success in supporting independent oncology practices nationwide THE WOODLANDS, TEXAS, Sept. 20, 2021 — The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that it has appointed Jason Hammonds as its new president. Hammonds has […]
Read MoreJune 4, 2021
Over 80 percent of non-small cell lung cancer detected at Stage 4 Fewer than 50 percent of patients had five or more biomarker tests Median time from diagnosis to first-line therapy is about five weeks THE WOODLANDS, TEXAS, June 4, 2021 — Results from the first phase of the broad, collaborative MYLUNG ConsortiumTM research study […]
Read MoreJune 3, 2021
Key highlights include a plenary session on cervical cancer among women in developing nations and an oral abstract exploring molecular testing and targeted therapy for metastatic non-small cell lung cancer, among other topics THE WOODLANDS, Texas, June 3, 2021 — US Oncology Research, The US Oncology Network (The Network), and OntadaTM announce they contributed to […]
Read MoreApril 1, 2021
By joining The Network, these physicians contribute to the expansion of colorectal services in Texas THE WOODLANDS, Texas, April 1, 2021—The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, continues to expand its reach into local communities while broadening its surgical expertise […]
Read MoreMarch 25, 2021
Eight custom measures receive approval, raising the bar on oncology patient care IRVING, Texas, March 25, 2021 — For the fifth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). As a CMS-approved QCDR, Practice Insights, a […]
Read MoreFebruary 4, 2021
Unique, collaborative real-world research consortium will study up to 12,000 NSCLC patients in the community setting over five years MYLUNG to deepen understanding of barriers and address challenges to improve care for lung cancer patients, including those with targetable mutations The MYLUNG consortium – or “Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: […]
Read MoreDecember 2, 2020
Top researchers to present the latest clinical findings advancing treatment options for blood cancers and other hematologic diseases THE WOODLANDS, Texas, Dec. 2, 2020 — During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, principal investigators from The US Oncology Network (The Network) and US Oncology Research will share detailed results from […]
Read MoreNovember 11, 2020
Community-based practices in The Network advance value-based care by significantly reducing costs while enhancing care THE WOODLANDS, TEXAS, Nov. 11, 2020—The US Oncology Network (The Network) reached a major milestone recently in its journey to provide high-quality, value-based care to local communities by enrolling its 100,000th patient in the Centers for Medicare & Medicaid Innovation’s […]
Read More
